Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.97
Delayed Data
As of Jun 24
 -0.62 / -1.79%
Today’s Change
28.25
Today|||52-Week Range
36.46
+5.24%
Year-to-Date
10 Companies for Enterprising Dividend Investors - June
4:17pm / GuruFocus News - Paid Partner Content
Paratek Reports Positive Phase III Data on Antibiotic Drug
Jun 17 / Zacks.com - Paid Partner Content
The 5 Best Healthcare ETFs
7:22am / MotleyFool.com - Paid Partner Content
Medivation's (MDVN) Pidilizumab Positive in Phase I/II Study
Jun 17 / Zacks.com - Paid Partner Content
Stocks Benjamin Graham Would Buy Today
Jun 24 / GuruFocus News - Paid Partner Content
Don't Make it Complicated, Own Drug Stocks
Jun 16 / Zacks.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
Emergent (EBS) BioThrax Gets Orphan Status in the U.S.
Jun 16 / Zacks.com - Paid Partner Content
Retrophin (RTRX) RE-024 Positive in Physician-Initiated Study
Jun 24 / Zacks.com - Paid Partner Content
Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
Jun 15 / Zacks.com - Paid Partner Content
Why Pfizer (PFE) is a Great Stock to Buy for the Long Run
Jun 23 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Reports Positive Trial Results on Victoza
Jun 15 / Zacks.com - Paid Partner Content
Corporate Share Buybacks Rise to Record Level in First Quarter
Jun 23 / GuruFocus News - Paid Partner Content
Jazz Pharmaceuticals Offers HAL Study Data on JZP-110
Jun 15 / Zacks.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
Infinity (INFI) at 52-Week Low on Disappointing Duvelisib Data
Jun 15 / Zacks.com - Paid Partner Content
Nymox (NYMX) Stock Up on Positive 7-Year Fexapotide Data
Jun 23 / Zacks.com - Paid Partner Content
Zacks Industry Rank Analysis Highlights: Pfizer, Bristol-Myers Squibb and H Lundbeck
Jun 15 / Zacks.com - Paid Partner Content
Epizyme Teams Up with Roche's Genentech for Tazemetostat
Jun 23 / Zacks.com - Paid Partner Content
ICON and Pfizer Extend Ties, Sign New Agreement
Jun 15 / Zacks.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: We Need More Mergers Right Now
Jun 22 / TheStreet.com - Paid Partner Content
Shire Gets Breakthrough Status for Rare Disease Candidates
Jun 14 / Zacks.com - Paid Partner Content
Share Buybacks Rise to Record Level in First Quarter
Jun 22 / GuruFocus News - Paid Partner Content
Abbott Labs (ABT) Reports Positive Data on FreeStyle Libre
Jun 14 / Zacks.com - Paid Partner Content
Investors Cautious in Trading as Stocks End Day Lower
Jun 22 / GuruFocus News - Paid Partner Content
Don't Make It Complicated, Own Drug Stocks
Jun 14 / Zacks.com - Paid Partner Content
RedHill (RDHL) Stock Up on Positive Phase I Data on Yeliva
Jun 22 / Zacks.com - Paid Partner Content
If I Plan On Investing My Social Security, What Dividend Stocks Can I Buy?
Jun 14 / MotleyFool.com - Paid Partner Content
U.S. Market Indexes Gain as Investors Await UK Vote
Jun 21 / GuruFocus News - Paid Partner Content
Revance's Lead Candidate Fails in Phase III Crow's Feet Study
Jun 14 / Zacks.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
Marinus Stock Down on Dismal Phase III Data on Ganaxolone
Jun 14 / Zacks.com - Paid Partner Content
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
Should Pfizer Buy This Beaten-Down Immuno-Oncology Company?
Jun 14 / MotleyFool.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
Pfizer, New York & Company, Wal-Mart Stores, Amazon and Alibaba Home highlighted as Z...
Jun 13 / Zacks.com - Paid Partner Content
Vical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine
Jun 21 / Zacks.com - Paid Partner Content
Agios Reports Favorable Phase II PK Deficiency Study Data
Jun 13 / Zacks.com - Paid Partner Content
Perrigo Sells Vitamins Business to IVC
Jun 20 / TheStreet.com - Paid Partner Content
Bull of the Day: Pfizer (PFE)
Jun 13 / Zacks.com - Paid Partner Content
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun 20 / Zacks.com - Paid Partner Content
Pfizer Reveals Final Phase III Data on Inotuzumab Ozogamicin
Jun 13 / Zacks.com - Paid Partner Content
Stock Market News for June 20, 2016
Jun 20 / Zacks.com - Paid Partner Content
Dividend Stocks Retirees Can Buy
Jun 12 / MotleyFool.com - Paid Partner Content
Emergent (EBS) BioThrax sBLA Accepted for FDA Review
Jun 20 / Zacks.com - Paid Partner Content
Cancer therapy re-engineers cells to hunt and destroy
Jun 02 / FT.com - Paid Partner Content
3 Top Big Pharma Stocks to Buy Now
Jun 19 / MotleyFool.com - Paid Partner Content
President raises patient and business hope for cancer treatment
Jun 02 / FT.com - Paid Partner Content
Wall Street heads for second straight weekly loss
Jun 17 / FT.com - Paid Partner Content
M&A back on the table as 'big pharma' targets smaller rivals
Jun 02 / FT.com - Paid Partner Content